NCT04451746View on ClinicalTrials.gov

The Influence of Combined Oral Contraception on the DEvelopment and progRession of Chronic venoUs diSeases

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 24, 2020

Primary Completion Date

July 24, 2025

Study Completion Date

August 24, 2025

Conditions
Chronic Venous Diseases
Interventions
DRUG

Combined Oral Contraceptive

The investigators consistently include patients who have been prescribed hormonal tablets for contraception, namely 1) COCs with bioidentical estrogen; 2) COCs with ethinyl estradiol 30mkg according to the scheme 21 + 7; 3) COCs with ethinyl estradiol 20mkg according to the scheme 21 + 7.

Trial Locations (1)

454090

RECRUITING

Clinic of phlebology and laser surgery, Chelyabinsk

All Listed Sponsors
lead

Clinic of Phlebology and Laser Surgery, Chelyabinsk, Russia

OTHER